Current Focus – Sustainable Drug Access & Treatment Monitoring
We believe in joining our voices with fellow cancer patient organizations as well as other not-for-profit/charitable organizations who dedicate their work to finding better ways to help everyone access affordable, sustainable and safe medicines.
Here are three issues we are currently passionate about:
Additionally, we believe that the introduction of generic oral cancer drugs in Canada can play an important role towards sustainable drug costs. We have carefully examined the issue of generic imatinib and are pleased to provide our position on the use of generic imatinib for Canadian CML patients. Please visit our position statement by clicking on this link:
Even the WHO believes that Cancer medicine isn’t just for the wealthy. They’ve added Gleevec (TM) to their essential medicines list: